埃沃洛库马布诱导的血管:第一个记录的病例和对罕见不良事件的审查
Bola Habeb1, Paula Derias2, John Retzloff1
1Department of Internal Medicine, Florida State University - Ascension Sacred Heart Hospital, Pensacola, Florida, USA.
一个罕见的口腔血管发病例发生在一个家族高胆固醇血症患者身上,该患者接受了evolocumab (PCSK9抑制剂) 治疗. 这种过敏反应在停止服用药物后消失,这表明潜在的免疫中介反应.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 作为PCSK9抑制剂的Evolocumab治疗了对他类药物和ezetimibe不反应的高脂血症.
- 虽然通常是安全的,但罕见的过敏反应,如血管是可能的.
- 家族性高胆固醇血症是一种遗传疾病,导致高的LDL胆固醇.
研究的目的:
- 报告第一个与evolocumab相关的血管的病例,没有混因素.
- 为了突出一个潜在的免疫介导的evolocumab的不良影响.
主要方法:
- 一个64岁的男性患有家族性高胆固醇血症的病例报告.
- 临床评估和实验室研究,以排除血管的常见原因.
- 停止治疗evolocumab并监测症状的消失.
主要成果:
- 患者在开始使用evolocumab的4个月后出现了急性口腔面血管.
- 血管的常见原因被排除在外.
- 症状在停止使用evolocumab后迅速消失,没有复发.
结论:
- 血管可能是对evolocumab的免疫中介反应.
- 对免疫机制的进一步研究是有必要的.
- 免疫分析可以确定患有这种不良影响风险的患者.
更多相关视频
10:34Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Allergic Drug Reactions
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
